| http://www.w3.org/ns/prov#value | - Therefore, biological modifiers of Th2 immune pathways are a rational approach for developing new treatments for severe asthma that could be added when standard therapies, such as inhaled corticosteroids plus long-acting ??2-agonists or oral corticosteroids, do not provide adequate control.
|
